ACLS tachycardia algorithm: Managing stable tachycardia

Written by

Version control: Our ACLS, PALS & BLS courses follow 2020 American Heart Association Guidelines for CPR and ECC. American Heart Association guidelines are updated every five years. If you are reading this in January 2026 or later, please and we will update this page.

For tachycardia, assess appropriateness for clinical considering and treating the underlying cause. Tachycardia is heart rate over 150 beats per minute. Maintain a patent airway and assist breathing as necessary. Administer oxygen if hypoxic. Place the patient on a cardiac monitor to identify rhythm and monitor blood pressure and oximetry.

Printed crash cart cards

ACLS crash cart algorithm pocket cards

Order the full set of printed crash cart cards.

Downloadable PDF

ACLS tachycardia algorithm: Managing stable tachycardia PDF preview

Save this algorithm for offline review.

Download PDF

Persistent tachycardia can cause hypotension, acutely altered mental status, signs of shock, ischemic chest discomfort, and acute heart failure. If the patient is having any of these signs consider emergent synchronized cardioversion, follow your manufacturer's guidelines. Consider sedation prior to cardioversion but do not delay treatment. If the rhythm is regular with narrow complexes, consider adenosine 6 mg IV rapid push.

If the patient is stable, measure the QRS. If QRS is wider than 0.12 seconds, establish IV access and obtain a 12 lead ECG. Consider adenosine only if the rhythm is regular and monomorphic. Consider antiarrhythmic infusions such as procainamide, amiodarone, or sotalol IV. Consider an expert consultation.

If QRS is less than 0.12 seconds, establish IV and obtain 12 lead ECG. If the rhythm is regular, encourage the patient to try a vagal maneuver. Give adenosine 6 mg IV rapid push if the rhythm is regular. Consider a beta blocker or calcium channel blocker and seek expert consultation.

For synchronized cardioversion, follow your manufacturer’s guidelines. Initial recommended doses for a narrow regular rhythm (SVT) is 100 Joules. For narrow irregular rhythm (atrial fibrillation or atrial flutter) use 200 Joules. For a wide and regular rhythm use 100 Joules. For a wide irregular rhythm, treat as ventricular fibrillation with immediate unsynchronized defibrillation at 200 Joules biphasic or 360 J monophasic.

Adenosine is given as a rapid IV push. First dose is 6 mg followed by a normal saline flush. If a second dose is required, give 12 mg IV rapid push.

Antiarrhythmic infusions for a stable wide-QRS consider Procainamide, Amiodarone or Sotalol IV. Procainamide dose is 20–50 mg/min until the arrhythmia is suppressed, the patient becomes hypotensive, the QRS duration increases more than 50% or the maximum dose of 17 mg/kg is reached. Followed by a maintenance infusion of 1–4 mg/min. Avoid Procainamide if QT is prolonged or the patient has signs of heart failure. Amiodarone is given as a first dose of 150 mg over 10 minutes. Repeat as needed if VT recurs. Follow by a maintenance infusion of 1 mg/min for the first 6 hours. Sotalol is given 100 mg (1.5 mg/kg) over 5 minutes. Avoid if the patient has a prolonged QT.

Get the auto reminder for recertification.

Planning to certify/recertify ACLS?

Get a reminder when you need to take the exam

Loading... Thanks, email containing all the resources sent to your inbox. Mail failed, Please recheck your email address and try again. Please enter a valid email address.

Please verify or enter a different email address:

How we reviewed this article

Our experts continually monitor the medical science space, and we update our articles when new information becomes available.

Current version
Nov 26, 2025
Changes: Updated synchronized cardioversion energy recommendations
Jul 1, 2021

Written by: